KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 153 filers reported holding KRYSTAL BIOTECH INC in Q3 2022. The put-call ratio across all filers is 3.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,400 | -32.1% | 4,400 | -31.2% | 0.00% | 0.0% |
| Q2 2023 | $751,360 | +23.5% | 6,400 | -15.8% | 0.00% | 0.0% |
| Q1 2023 | $608,456 | -38.1% | 7,600 | -38.7% | 0.00% | -50.0% |
| Q4 2022 | $982,328 | +13.3% | 12,400 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $867,000 | -77.1% | 12,450 | -78.4% | 0.00% | -50.0% |
| Q2 2022 | $3,787,000 | +90.5% | 57,689 | +93.1% | 0.00% | +300.0% |
| Q1 2022 | $1,988,000 | +34.2% | 29,880 | +41.2% | 0.00% | 0.0% |
| Q4 2021 | $1,481,000 | +177.3% | 21,159 | +169.2% | 0.00% | – |
| Q2 2021 | $534,000 | -11.7% | 7,859 | +0.1% | 0.00% | -100.0% |
| Q1 2021 | $605,000 | +26.6% | 7,853 | -1.3% | 0.00% | – |
| Q4 2020 | $478,000 | +39.0% | 7,959 | -0.6% | 0.00% | – |
| Q3 2020 | $344,000 | -4.7% | 8,006 | -8.0% | 0.00% | – |
| Q2 2020 | $361,000 | -61.5% | 8,705 | -59.8% | 0.00% | -100.0% |
| Q1 2020 | $937,000 | -45.8% | 21,652 | -30.7% | 0.00% | -50.0% |
| Q4 2019 | $1,730,000 | +94.2% | 31,235 | +22.6% | 0.00% | +100.0% |
| Q3 2019 | $891,000 | -12.9% | 25,476 | +0.4% | 0.00% | 0.0% |
| Q2 2019 | $1,023,000 | -11.8% | 25,381 | -28.0% | 0.00% | 0.0% |
| Q1 2019 | $1,160,000 | – | 35,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |